123 related articles for article (PubMed ID: 12652958)
1. [Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].
Gadzhiev AN
Ter Arkh; 2003; 75(1):51-5. PubMed ID: 12652958
[TBL] [Abstract][Full Text] [Related]
2. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
[TBL] [Abstract][Full Text] [Related]
3. Quinapril in chronic heart failure.
Northridge DB; Dargie HJ
Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
[TBL] [Abstract][Full Text] [Related]
4. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
5. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
[TBL] [Abstract][Full Text] [Related]
6. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
Kromer EP; Elsner D; Riegger GA
J Cardiovasc Pharmacol; 1990 Jul; 16(1):9-14. PubMed ID: 1696671
[TBL] [Abstract][Full Text] [Related]
7. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
Riegger GA
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
Sedman AJ; Posvar E
Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
[TBL] [Abstract][Full Text] [Related]
9. Quinapril in patients with congestive heart failure: controlled trial versus captopril.
Acanfora D; Furgi G; Trojano L; Picone C; Iannuzzi GL; Rossi M; Papa A; Rengo C; Rengo F
Am J Ther; 1997; 4(5-6):181-8. PubMed ID: 10423609
[TBL] [Abstract][Full Text] [Related]
10. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
Haleen SJ; Weishaar RE; Overhiser RW; Bousley RF; Keiser JA; Rapundalo SR; Taylor DG
Circ Res; 1991 May; 68(5):1302-12. PubMed ID: 1850330
[TBL] [Abstract][Full Text] [Related]
11. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
[TBL] [Abstract][Full Text] [Related]
13. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
[TBL] [Abstract][Full Text] [Related]
14. Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure.
Krum H; Karrasch J; Hamer A; Hare D; Howes LG; Jackson B; Leslie P
Am Heart J; 1998 Feb; 135(2 Pt 1):237-41. PubMed ID: 9489970
[No Abstract] [Full Text] [Related]
15. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
Oosterga M; Voors AA; Pinto YM; Buikema H; Grandjean JG; Kingma JH; Crijns HJ; van Gilst WH
Am J Cardiol; 2001 Mar; 87(5):542-6. PubMed ID: 11230836
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of heart failure in dogs with ACe inhibitors: comparison of quinapril and captopril].
Morisse B; Kersten U
Tierarztl Prax; 1995 Oct; 23(5):489-96. PubMed ID: 8585063
[TBL] [Abstract][Full Text] [Related]
17. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
Riegger GA
Eur Heart J; 1991 Jun; 12(6):705-11. PubMed ID: 1830551
[TBL] [Abstract][Full Text] [Related]
18. [The heart of the matter in cardiovascular therapy. ACE-inhibition with Quinapril: hypertension, myocardial infarction, cardiac insufficiency].
Fortschr Med Monogr; 1993; 68():1-23. PubMed ID: 7728496
[No Abstract] [Full Text] [Related]
19. Quinapril therapy in patients with chronic mitral regurgitation.
Schön HR; Schröter G; Barthel P; Schömig A
J Heart Valve Dis; 1994 May; 3(3):303-12. PubMed ID: 8087269
[TBL] [Abstract][Full Text] [Related]
20. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.
Pitt B; O'Neill B; Feldman R; Ferrari R; Schwartz L; Mudra H; Bass T; Pepine C; Texter M; Haber H; Uprichard A; Cashin-Hemphill L; Lees RS;
Am J Cardiol; 2001 May; 87(9):1058-63. PubMed ID: 11348602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]